Latest filing published 30 Jan 2018 for Seres Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Michele Trucksis: trading record in brief
All filings by Michele Trucksis on record concern Seres Therapeutics, Inc. In total, 6 filings cover trades dated from 27 July 2016 to 26 January 2018.
No open-market purchase appears, only 3 sales worth €1.4M. Besides market trades, the filings include 3 option exercises. 2018 to date brings no purchases and 1 sale.
The latest filing, published on 30 January 2018, reports an option exercise in Seres Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michele Trucksis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500 sharesCOMMON STOCKSEC:0000899243-18-002328:0
- 2,607 shares@ US$11.021.2% of flowCOMMON STOCKSEC:0000899243-18-002328:1
- 4,156 shares@ US$15.773.0% of flowCommon StockSEC:0000899243-16-025946:0
- 4,156 shares@ US$35.186.7% of flowCommon StockSEC:0000899243-16-025946:1
- 38,064 shares@ US$15.7727.6% of flowCommon StockSEC:0000899243-16-025822:0
- 38,064 shares@ US$35.1461.5% of flowCommon StockSEC:0000899243-16-025822:1
6 of 6 declarations
